New depression pill tested as add-on therapy
Disease control
Completed
This study tested whether adding an experimental medication called SPN-820 to existing antidepressant therapy could help adults with major depression. Forty participants took SPN-820 every three days for 10 days while continuing their regular medication. Researchers measured chan…
Phase: PHASE2 • Sponsor: Navitor Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC